Quest Diagnostics (DGX) Gross Profit (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Gross Profit data on file, last reported at $942.0 million in Q1 2026.

• Quarterly Gross Profit rose 9.15% year-over-year to $942.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 billion (up 12.23% YoY) and the FY2025 annual result came in at $3.7 billion, up 12.98% from the prior year.
• Gross Profit climbed to $942.0 million in Q1 2026 per DGX's latest filing, from $910.0 million in the prior quarter.
• The five-year high for Gross Profit was $965.0 million in Q1 2022, with the low at $736.0 million in Q4 2023.
• Average Gross Profit over 5 years is $843.4 million, with a median of $842.0 million recorded in 2022.
• Year-over-year, Gross Profit declined 26.12% in 2022 and rose 17.29% in 2025.
• Quest Diagnostics' Gross Profit stood at $758.0 million in 2022, then declined by 2.9% to $736.0 million in 2023, then gained by 16.58% to $858.0 million in 2024, then grew by 6.06% to $910.0 million in 2025, then rose by 3.52% to $942.0 million in 2026.
• Business Quant data shows DGX's Gross Profit at $942.0 million in Q1 2026, $910.0 million in Q4 2025, and $949.0 million in Q3 2025.